Research progress of interleukin-22 in chronic metabolic diseases
Author:
Affiliation:

(Central Laboratory of Second Affiliated Hospital of Nanjing Medical University, Key Laboratory of Aging and Related Diseases of Nanjing Medical University, Nanjing 210011, China)

Clc Number:

R589

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Interleukin-22 (IL-22) , a member of the IL-10 cytokine family, is secreted by a variety of immune cells. Its receptor (IL-22R) is mainly expressed in non-hematopoietic endothelial cells and stromal cells. IL-22 plays important roles in mucosal barrier defense, tissue repair, epithelial cell survival and proliferation by binding to its receptor. The expression of IL-22 is closely associated with various metabolic diseases, and has become a hot topic in the field of metabolism in recent years. This article reviews the research progress of IL-22 in fatty liver disease, obesity, diabetes and other chronic metabolic diseases.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 14,2019
  • Revised:
  • Adopted:
  • Online: November 30,2020
  • Published: